The US FDA has approved a new non-opioid painkiller, Journavx, by Vertex Pharmaceuticals, which targets pain signals before reaching the brain to provide relief for moderate to severe pain without the addictive potential of opioids. Clinical trials showed effectiveness in reducing post-surgery pain, marking an important milestone in acute pain management amidst the opioid crisis in the US. Priced at $15.50 per capsule, Journavx is the first new class of pain medicine approved in over 20 years, offering hope for the 80 million Americans prescribed pain medication annually.
Full Article
35 Funny Tweets That Sum Up Parenting In Numbers
Parenting is humorously broken down into various percentages by funny parents on X, with examples like 67% trying not to laugh at silly situations and 50% dealing with kids' TV restrictions. Other breakdowns include 40% handling kids' social calendars, 20% eating in secret, and 30% crying. Overall, these amusing pie charts capture the chaotic and relatable essence of parenting in a lighthearted way. Full Article
Read more